Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 46 out of 100. Long-term cohort studies

Topic: Risk, prevention and care in population studies

The mean age of the sample was 63 years (Q1, Q3, 56, 68); 56% were women. For short sleepers, increasing sleep duration was associated with a lowering of dementia risk when at the expense of inactivity or light activity, but not when at the expense of MVPA. For normal sleepers, the effect of increasing or decreasing sleep duration on dementia risk differed for all three substituted behaviors (i.e., inactivity, light, or MVPA). Most notably, increasing sleep at the expense of MVPA was associated with greater dementia risk, and increasing MVPA at the expense of sleep was associated with lower dementia risk. The interpretation of the results was broadly consistent when using MRI-based outcomes (e.g., hippocampal volume) in a subset with brain imaging (n = 15,180). Our findings from this observational analysis suggest that personalized approaches that balance trade-offs between sleep duration and differing physical activity levels based on individual circumstances, such as habitual sleep duration, may be important for dementia risk reduction.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Yiallourou, S. R., Cribb, L., Campbell‐Brown, B., Brakenridge, C. J., Baril, A., & Pase, M. P. (2025). Sleep and physical activity trade-offs and dementia risk: a prospective cohort study in UK Biobank participants. BMC Medicine. https://doi.org/10.1186/s12916-025-04536-7

Vancouver

Yiallourou SR, Cribb L, Campbell‐Brown B, Brakenridge CJ, Baril A, Pase MP. Sleep and physical activity trade-offs and dementia risk: a prospective cohort study in UK Biobank participants. BMC Medicine. 2025. doi:10.1186/s12916-025-04536-7. PMID: 41331463.

BibTeX

@article{yiallourou2025-41331463,
  author  = {Yiallourou, Stephanie R and Cribb, Lachlan and Campbell‐Brown, Beaudan and Brakenridge, Christian John and Baril, Andrée‐Ann and Pase, Matthew Paul},
  title   = {{Sleep and physical activity trade-offs and dementia risk: a prospective cohort study in UK Biobank participants}},
  journal = {BMC Medicine},
  year    = {2025},
  doi     = {10.1186/s12916-025-04536-7},
  pmid    = {41331463},
  url     = {https://doi.org/10.1186/s12916-025-04536-7}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In this UK Biobank cohort, for short sleepers, increasing sleep duration lowered dementia risk only when it replaced inactivity or light activity, not moderate-to-vigorous activity. For normal sleepers, replacing moderate-to-vigorous activity with sleep was linked to greater dementia risk, suggesting that balancing sleep and activity may matter for risk reduction.

Study details

How this study scored 46/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 46 of 100.46 of 100 points earned54 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (BMC Medicine)
Journal's citation record 3 / 4 BMC Medicine: journal h-index 259 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 15,180 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Matthew Paul Pase: h-index 49 (OpenAlex, whole career)
Institution's track record 1 / 3 Monash University: institution h-index 1,146 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 6 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41331463)
Free to read 2 / 2 Free to read
Total 46 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Long-term cohort studies

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Similar studies

More on Long-term cohort studies

See all studies in Long-term cohort studies →